Cartesian Therapeutics Inc. (RNAC) — Free Cash Flow Generation Index
Cartesian Therapeutics Inc. (RNAC) has a Free Cash Flow Generation Index of 0.55x as of September 2024. Free cash flow of $7.49 Million represents 1% of operating cash flow ($13.69 Million). Explore Cartesian Therapeutics Inc. capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Cartesian Therapeutics Inc. Free Cash Flow Generation Index (2020–2020)
Historical FCF Generation Index trend for Cartesian Therapeutics Inc. across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Cartesian Therapeutics Inc..
Annual Free Cash Flow Generation for Cartesian Therapeutics Inc. (2020–2020)
Year-by-year Free Cash Flow Generation Index for Cartesian Therapeutics Inc.. Check Cartesian Therapeutics Inc. investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.98x | $34.07 Million | $34.88 Million | $815.00K | — |